— Know what they know.
Not Investment Advice

CARM OTC

Carisma Therapeutics, Inc.
1W: -37.5% 1M: -28.6% 3M: -91.5% YTD: -98.9% 1Y: -99.8% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±41.6%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 42 · $20923 mcap · 30M float · 0.080% daily turnover · Short 39% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 2Hold: 4Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$—
Analysts0
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2024-04-11 BTIG Justin Zelin Initiated $6 — +214.1% $1.91

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Sep 29, 2026
DCF
5
ROE
1
ROA
5
D/E
1
P/E
3
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CARM receives an overall rating of B. Strongest factors: DCF (5/5), ROA (5/5). Areas of concern: ROE (1/5), D/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-01-13 B- B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 20 Grade D
Profitability
80
Balance Sheet
61
Earnings Quality
22
Growth
88
Value
56
Momentum
0
Safety
0
Cash Flow
18
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CARM scores highest in Growth (88/100) and lowest in Momentum (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-44.98
Distress Zone
Piotroski F-Score
3/9
✓ ✗ ✓ ✗ ✗ ✗ ✗ ✗ ✓
Beneish M-Score
28.29
Possible Manipulator
Ohlson O-Score
-0.21
Bankruptcy prob: 44.8%
Moderate
Credit Rating
B-
Score: 20.0/100
Trend: Stable
Earnings Quality
25/100
OCF/NI: -2.79x
Accruals: 125.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CARM scores -44.98, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CARM scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CARM's score of 28.29 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CARM's implied 44.8% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CARM receives an estimated rating of B- (score: 20.0/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CARM's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
0.00x
PEG
0.00x
P/S
0.00x
P/B
-0.02x
P/FCF
-0.51x
P/OCF
—
EV/EBITDA
0.69x
EV/Revenue
0.18x
EV/EBIT
0.79x
EV/FCF
-0.42x
Earnings Yield
69.98%
FCF Yield
-195.05%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 0.0x earnings, CARM trades at a deep value multiple. An earnings yield of 70.0% exceeds typical risk-free rates, suggesting equities are being compensated for risk.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.672
EBT / EBIT
×
EBIT Margin
0.227
EBIT / Rev
×
Asset Turnover
2.165
Rev / Assets
×
Equity Multiplier
-4.053
Assets / Equity
=
ROE
-134.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CARM's ROE of -134.1% is driven by Asset Turnover (2.165), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$1.63
Price/Value
0.17x
Margin of Safety
83.19%
Premium
-83.19%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CARM's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. At an intrinsic value of $1.63, CARM appears undervalued with a 83% margin of safety. The adjusted fair P/E of 8.5x compares to the current market P/E of 0.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
339.6%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Steven Kelly Current
President & Chief Executive Officer
$460,833 $— $3,504,425
Thomas R. Cannell,
D.V.M. Former President and Chief Executive Officer
$104,225 $— $3,132,710
Richard Morris Current
Chief Financial Officer
$384,302 $— $1,662,801
Michael Klichinsky, Pharm.D.,
Ph.D. Current Chief Scientific Officer
$345,625 $— $1,603,377
Monica Forbes Financial
ief Financial Officer and Treasurer
$72,269 $— $1,349,748
Mark Sullivan Counsel,
eneral Counsel, Chief Compliance Officer and Corporate Secretary
$69,058 $— $1,123,328

CEO Pay Ratio

8:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,504,425
Avg Employee Cost (SGA/emp): $437,783
Employees: 46

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
46
-57.0% YoY
Revenue / Employee
$426,783
Rev: $19,632,000
Profit / Employee
$-1,314,717
NI: $-60,477,000
SGA / Employee
$437,783
Avg labor cost proxy
R&D / Employee
$1,297,239
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
ROE 1.2% -8.6% -4.4% -1.2% -81.1% -23.8% -1.6% -55.4% -8.4% -57.6% -3.1% -12.2% 1.3% -1.7% -2.2% -3.6% 87.8% 3.9% 2.2% -1.3% -1.34%
ROA -14.8% -82.1% -59.7% -52.1% -26.3% -10.5% -16.2% -22.0% -31.8% -39.0% -69.1% -85.0% -1.1% -70.6% -75.4% -85.7% -1.0% -1.1% -1.5% 33.1% 33.09%
ROIC 39.4% 21.2% 21.9% 2.0% -1.9% -6.6% 41.9% 46.3% 26.3% 1.1% 1.3% 1.4% 1.5% 1.7% 1.6% 1.5% 1.1% 97.6% 78.7% -3.8% -3.76%
ROCE -12.3% -69.6% -45.2% -40.0% -21.8% -9.7% -30.8% -95.7% -1.1% -51.3% -66.1% -87.1% -1.2% -1.4% -1.7% -2.1% -4.3% -9.4% 11.7% -46.4% -46.40%
Gross Margin — -85.9% — — 99.9% 73.5% -4.3% -5.0% -3.8% 78.3% -4.2% -4.1% 51.4% -4.1% -66.4% 1.0% 81.7% 1.0% — 1.0% 1.00%
Operating Margin — -1.6% — — 21.8% -12.4% -5.2% -6.5% -4.1% -7.1% -5.9% -5.8% -5.2% -5.7% -1.3% -3.9% -4.9% -2.5% — 96.8% 96.83%
Net Margin — -12.9% — — 44.7% -13.8% -5.5% -7.1% -4.5% -7.6% -5.6% -5.6% -4.9% -5.6% -1.2% -3.8% -4.8% -2.5% — 98.8% 98.82%
EBITDA Margin — -12.8% — — 44.8% -12.8% -5.1% -6.2% -3.9% -6.9% -5.7% -5.7% -4.7% -5.2% -1.2% -3.7% -4.6% -2.3% — 98.8% 98.82%
FCF Margin -2.0% -2.6% -3.5% -15.0% -2.8% -80.7% -38.0% -19.0% -1.2% -5.8% -5.7% -6.0% -5.5% -5.2% -3.7% -3.4% -3.1% -2.4% -3.5% -42.6% -42.59%
OCF Margin -2.7% -2.6% -3.5% -15.0% -2.8% -75.9% -29.6% -2.4% -76.9% -5.5% -5.5% -5.9% -5.4% -5.2% -3.7% -3.3% -3.1% -2.4% -3.5% -42.6% -42.59%
ROA 3Y Avg snapshot only -35.47%
ROIC Economic snapshot only -9.37%
Cash ROA snapshot only -3.42%
NOPAT Margin snapshot only 20.61%
Pretax Margin snapshot only 15.28%
R&D / Revenue snapshot only 51.97%
SGA / Revenue snapshot only 31.12%
SBC / Revenue snapshot only 4.20%
Valuation
Metric Trend Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
P/E Ratio -3.02 -1.45 -3.37 -0.75 -1.05 -2.35 -10.10 -4.09 -3.41 -1.67 -4.44 -2.06 -1.36 -1.14 -0.87 -0.64 -0.29 -0.26 -0.33 1.43 0.001
P/S Ratio 6.02 11.17 22.16 15.72 2.84 2.45 11.79 5.57 21.20 10.18 26.93 11.87 7.93 6.17 3.05 2.01 0.88 0.65 1.52 0.22 0.000
P/B Ratio -7.33 18.73 6.98 0.42 0.40 0.30 -19.02 -4.44 -1.33 1.45 5.29 3.68 4.46 8.53 175.41 -3.67 -0.62 -0.35 -0.36 -13.25 -0.024
P/FCF -3.08 -4.29 -6.36 -1.05 -1.00 -3.04 -30.99 -29.32 -17.06 -1.75 -4.71 -1.99 -1.44 -1.18 -0.83 -0.60 -0.29 -0.27 -0.44 -0.51 -0.513
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -0.59 -0.54 -1.93 1.21 1.43 5.77 -9.31 -3.70 -3.59 0.13 -3.29 -1.00 -0.52 -0.53 -0.35 -0.28 -0.02 -0.15 -0.37 0.69 0.694
EV/Revenue 1.09 4.09 12.44 -24.94 -3.85 -5.70 10.01 4.43 20.00 -0.71 18.40 5.50 2.94 2.81 1.21 0.85 0.05 0.38 1.49 0.18 0.180
EV/EBIT -0.59 -0.54 -1.92 1.20 1.42 5.62 -9.07 -3.57 -3.47 0.13 -3.17 -0.97 -0.49 -0.50 -0.33 -0.26 -0.02 -0.15 -0.35 0.79 0.792
EV/FCF -0.56 -1.57 -3.57 1.66 1.36 7.06 -26.31 -23.35 -16.09 0.12 -3.22 -0.92 -0.53 -0.54 -0.33 -0.25 -0.02 -0.16 -0.43 -0.42 -0.423
Earnings Yield -33.1% -68.8% -29.7% -1.3% -95.4% -42.5% -9.9% -24.5% -29.4% -59.7% -22.5% -48.5% -73.4% -87.4% -1.1% -1.6% -3.5% -3.9% -3.0% 70.0% 69.98%
FCF Yield -32.5% -23.3% -15.7% -95.6% -99.7% -32.9% -3.2% -3.4% -5.9% -57.3% -21.2% -50.2% -69.5% -85.1% -1.2% -1.7% -3.5% -3.7% -2.3% -2.0% -1.95%
PEG Ratio snapshot only 0.000
EV/Gross Profit snapshot only 0.184
Acquirers Multiple snapshot only 0.874
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Current Ratio 3.48 7.29 9.30 15.92 17.77 21.32 6.40 1.35 2.78 6.73 6.80 7.53 5.06 4.64 3.25 3.23 1.48 1.34 0.48 0.86 0.862
Quick Ratio 3.48 7.29 9.30 15.92 17.77 21.32 6.40 1.35 2.78 6.73 6.80 7.53 5.06 4.64 3.25 3.23 1.48 1.34 0.48 0.86 0.862
Debt/Equity -0.00 0.00 0.00 0.00 0.00 0.00 -2.72 -1.26 -0.26 0.06 0.08 0.06 0.12 0.69 10.44 -0.30 -0.09 -0.06 -0.04 -0.88 -0.879
Net Debt/Equity — -11.86 -3.06 -1.09 -0.95 -0.98 — — — -1.55 -1.68 -1.97 -2.81 -4.64 -105.97 — — — — — —
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.41 0.47 0.56 0.04 0.04 0.03 0.03 0.10 0.06 0.08 0.08 0.15 0.34 0.12 0.116
Debt/EBITDA -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -1.57 -1.31 -0.73 -0.08 -0.07 -0.03 -0.04 -0.09 -0.05 -0.05 -0.04 -0.05 -0.04 0.06 0.056
Net Debt/EBITDA 2.66 0.93 1.51 1.97 2.49 8.26 1.66 0.95 0.22 2.00 1.53 1.16 0.88 0.63 0.54 0.38 0.28 0.11 0.01 -0.15 -0.148
Interest Coverage — — — — — -18.27 -13.47 -11.45 -15.32 -17.17 -23.40 -34.85 -60.13 — — — — — — — —
Equity Multiplier -20.42 20.11 4.88 1.46 1.82 1.31 -6.68 -2.68 -0.46 1.81 1.99 2.31 3.38 6.77 164.83 -3.78 -1.09 -0.44 -0.11 -7.56 -7.559
Cash Ratio snapshot only 0.408
Cash to Debt snapshot only 3.644
FCF to Debt snapshot only -29.416
Defensive Interval snapshot only 39.5 days
Efficiency & Turnover
Metric Trend Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Asset Turnover 0.07 0.11 0.09 0.03 0.10 0.10 0.14 0.16 0.05 0.06 0.11 0.15 0.18 0.13 0.22 0.27 0.33 0.44 0.33 2.17 2.165
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover — 10.77 13.50 7.79 2.31 10.69 20.43 47.16 0.94 24.24 — — — — 20.71 — 13.71 33.03 8.35 64.34 64.342
Payables Turnover 0.01 3.93 12.81 9.05 8.26 12.60 9.03 7.51 20.99 18.39 16.64 17.51 14.43 17.00 24.07 16.85 11.12 5.90 0.30 0.28 0.281
DSO 0 34 27 47 158 34 18 8 390 15 0 0 0 0 18 0 27 11 44 6 5.7 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 29459 93 28 40 44 29 40 49 17 20 22 21 25 21 15 22 33 62 1209 1300 1299.6 days
Cash Conversion Cycle -29459 -59 -1 7 114 5 -23 -41 373 -5 -22 -21 -25 -21 2 -22 -6 -51 -1165 -1294 -1293.9 days
Fixed Asset Turnover snapshot only 76.947
Cash Velocity snapshot only 18.953
Capital Intensity snapshot only 0.125
Growth (YoY)
Metric Trend Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Revenue — — — -61.6% 1.2% 33.9% 51.3% 5.1% -59.5% -41.1% -44.3% -45.0% 51.7% 23.0% 57.9% 41.1% 31.6% 32.4% -48.0% 1.6% 1.60%
Net Income 79.2% -1.0% -2.2% -1.2% -1.9% 81.8% 73.1% 60.4% 7.1% -2.4% -1.9% -1.3% -41.9% -8.9% 8.9% 22.8% 30.4% 37.5% 31.9% 1.1% 1.13%
EPS 80.6% -40.5% -1.1% -28.7% -73.9% 85.7% 94.1% 90.1% 77.0% 14.9% -1.9% -1.3% -41.4% -7.1% 11.7% 25.2% 32.2% 38.7% 32.3% 1.1% 1.12%
FCF 41.5% -36.6% -78.4% -1.4% -2.1% 58.5% 83.5% 92.3% 82.3% -3.3% -7.4% -16.3% -5.7% -10.6% -2.1% 20.1% 27.1% 39.7% 51.2% 67.2% 67.20%
EBITDA 80.6% -98.5% -2.2% -1.2% -2.1% 82.5% 74.8% 64.8% 16.0% -2.2% -1.9% -1.5% -54.3% -20.1% 2.7% 21.4% 30.7% 38.2% 39.0% 1.2% 1.22%
Op. Income 12.5% 34.8% 27.2% -10.7% 31.6% 6.9% -6.2% -3.0% -1.5% -1.7% -1.5% -1.2% -58.0% -23.6% 0.0% 18.2% 29.9% 39.0% 39.3% 1.2% 1.16%
OCF Growth snapshot only 66.87%
Asset Growth snapshot only -84.42%
Debt Growth snapshot only -77.03%
Shares Change snapshot only 0.95%
Growth (CAGR)
Metric Trend Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Revenue 3Y 2.0% — — — — — — — — — — 8.5% 9.9% -1.0% 10.0% 67.5% -6.9% -1.4% -22.9% 26.3% 26.33%
Revenue 5Y 62.6% 74.0% 68.7% -32.0% -4.1% -7.2% -4.7% 83.6% 87.4% — — — — — — — — — — 36.2% 36.18%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y 2.0% — — — — — — — — — — — — — — — — -0.2% 1.7% — —
Gross Profit 5Y 62.5% 50.5% — — — -33.2% -55.7% — — — — — — — — — — — — 35.7% 35.72%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 35.9% 32.4% 24.9% 25.5% 41.0% 28.9% -8.6% -9.8% -14.2% 14.3% 9.5% -0.7% -22.0% -26.6% -37.3% -43.7% -54.0% -58.7% -62.8% -57.9% -57.88%
Assets 5Y 38.6% 67.0% 91.9% 24.3% 24.6% 17.9% 0.5% 4.0% -0.8% 14.2% 1.5% -2.2% -4.3% -6.9% -14.2% -18.8% -23.2% -31.4% -45.2% -43.0% -43.01%
Equity 3Y — -27.0% -8.3% 47.3% 57.2% 65.6% — — — 67.1% — — — 5.5% -80.6% — — — — — —
Book Value 3Y — -55.5% -37.2% 7.0% 14.7% 20.8% — — — -14.0% — — — -39.1% -88.5% — — — — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Revenue Stability 0.33 0.36 0.35 0.40 0.03 0.04 0.02 0.55 0.46 0.58 0.58 0.50 0.36 0.44 0.58 0.58 0.37 0.55 0.21 0.51 0.509
Earnings Stability 0.15 0.63 0.46 0.70 0.30 0.29 0.19 0.12 0.08 0.14 0.07 0.10 0.08 0.07 0.00 0.00 0.01 0.03 0.01 0.17 0.167
Margin Stability 1.00 — — 0.00 0.12 0.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.50 0.50 0.50 0.00 1.00 1.00 1.00 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 1.00 1.000
Earn. Growth Consistency 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.97 0.50 0.50 0.50 0.83 0.96 0.96 0.91 0.88 0.85 0.87 0.20 0.200
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — -10.80 — — — 7.93 — — — 5.64 — — — -6.96 — — — — — — —
Gross Margin Trend — — — — — — — 1.71 -4.38 -3.30 -3.03 -0.53 0.21 -1.44 -0.12 0.83 2.11 3.09 3.23 2.82 2.820
FCF Margin Trend — — — — — — — 8.54 1.15 -4.13 -3.78 1.66 -3.48 -1.93 -0.65 -0.30 0.32 3.15 1.24 4.24 4.238
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — 49.4% 49.45%
Cash Flow Quality
Metric Trend Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
OCF/Net Income 1.38 0.34 0.53 0.72 1.05 0.73 0.25 0.02 0.12 0.91 0.90 1.02 0.93 0.96 1.04 1.06 0.99 0.94 0.76 -2.79 -2.787
FCF/OCF 0.71 1.00 1.00 1.00 1.00 1.06 1.29 8.05 1.62 1.06 1.04 1.01 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only -2.787
OCF/EBITDA snapshot only -1.641
CapEx/Revenue 78.7% 0.0% 0.3% 0.1% 0.0% 4.9% 8.5% 16.6% 47.4% 30.9% 22.9% 6.2% 7.6% 6.7% 4.2% 3.4% 0.6% 0.5% 0.0% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.000
Accruals Ratio 0.06 -0.54 -0.28 -0.15 0.01 -0.03 -0.12 -0.22 -0.28 -0.04 -0.07 0.02 -0.07 -0.03 0.03 0.05 -0.01 -0.07 -0.37 1.25 1.253
Sloan Accruals snapshot only -1.078
Earnings Quality Score snapshot only 0.250
Dividends & Buybacks
Metric Trend Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — 0.0% 0.00%
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — 0.0% 0.00%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -56.3% -62.2% -48.6% -2.9% -2.5% -2.0% -14.0% -0.1% -0.1% -24.6% -8.7% -18.0% -26.5% -3.2% -4.6% -7.4% -13.8% -0.9% -0.7% -0.2% -0.16%
Total Shareholder Return -56.3% -62.2% -48.6% -2.9% -2.5% -2.0% -14.0% -0.1% -0.1% -24.6% -8.7% -18.0% -26.5% -3.2% -4.6% -7.4% -13.8% -0.9% -0.7% -0.2% -0.16%
DuPont Factors
Metric Trend Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Tax Burden (NI/EBT) 1.07 1.01 1.02 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 1.03 1.06 1.10 1.08 1.08 1.04 1.01 0.98 0.95 0.96 0.96 0.98 0.98 1.08 0.67 0.672
EBIT Margin -1.86 -7.57 -6.46 -20.71 -2.70 -1.01 -1.10 -1.24 -5.77 -5.64 -5.80 -5.69 -5.95 -5.66 -3.67 -3.29 -3.16 -2.59 -4.26 0.23 0.227
Asset Turnover 0.07 0.11 0.09 0.03 0.10 0.10 0.14 0.16 0.05 0.06 0.11 0.15 0.18 0.13 0.22 0.27 0.33 0.44 0.33 2.17 2.165
Equity Multiplier -8.43 10.50 7.33 2.39 3.08 2.26 9.73 2.52 26.27 1.48 4.42 14.30 -1.24 2.37 2.87 4.23 -87.15 -3.48 -1.41 -4.05 -4.053
Per Share
Metric Trend Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
EPS (Diluted TTM) $-3.80 $-15.22 $-11.66 $-8.94 $-6.61 $-2.18 $-0.68 $-0.88 $-1.52 $-1.85 $-1.98 $-2.05 $-2.15 $-1.98 $-1.75 $-1.54 $-1.46 $-1.22 $-1.18 $0.19 $0.19
Book Value/Share $-1.57 $1.18 $5.63 $16.02 $17.22 $17.33 $-0.36 $-0.81 $-3.90 $2.14 $1.66 $1.15 $0.66 $0.27 $0.01 $-0.27 $-0.67 $-0.88 $-1.10 $-0.02 $-0.02
Tangible Book/Share $-11.65 $-6.39 $-1.15 $13.26 $14.43 $14.54 $-0.36 $-0.81 $-3.90 $2.14 $1.66 $1.15 $0.66 $0.27 $0.01 $-0.27 $-0.67 $-0.88 $-1.10 $-0.02 $-0.02
Revenue/Share $1.91 $1.98 $1.77 $0.43 $2.44 $2.09 $0.58 $0.65 $0.24 $0.30 $0.33 $0.36 $0.37 $0.37 $0.50 $0.49 $0.47 $0.48 $0.26 $1.25 $1.08
FCF/Share $-3.73 $-5.15 $-6.18 $-6.45 $-6.91 $-1.69 $-0.22 $-0.12 $-0.30 $-1.78 $-1.86 $-2.12 $-2.04 $-1.93 $-1.84 $-1.65 $-1.45 $-1.14 $-0.89 $-0.53 $-0.10
OCF/Share $-5.23 $-5.15 $-6.17 $-6.45 $-6.91 $-1.58 $-0.17 $-0.02 $-0.19 $-1.68 $-1.79 $-2.10 $-2.01 $-1.91 $-1.82 $-1.63 $-1.45 $-1.14 $-0.89 $-0.53 $-0.10
Cash/Share $9.40 $14.00 $17.22 $17.43 $16.31 $17.02 $2.03 $1.76 $1.29 $3.45 $2.91 $2.34 $1.92 $1.42 $1.01 $0.65 $0.45 $0.19 $0.05 $0.07 $0.07
EBITDA/Share $-3.53 $-14.98 $-11.43 $-8.84 $-6.54 $-2.06 $-0.63 $-0.78 $-1.36 $-1.66 $-1.82 $-1.96 $-2.09 $-1.96 $-1.71 $-1.49 $-1.41 $-1.18 $-1.04 $0.33 $0.33
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.99 $1.02 $1.00 $0.14 $0.13 $0.07 $0.08 $0.18 $0.09 $0.08 $0.06 $0.06 $0.04 $0.02 $0.02
Net Debt/Share $-9.40 $-14.00 $-17.22 $-17.43 $-16.31 $-17.02 $-1.04 $-0.73 $-0.29 $-3.32 $-2.78 $-2.27 $-1.84 $-1.24 $-0.92 $-0.57 $-0.39 $-0.13 $-0.01 $-0.05 $-0.05
Academic Models
Metric Trend Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -44.976
Altman Z-Prime snapshot only -126.269
Piotroski F-Score 2 3 3 2 2 5 3 3 1 2 4 3 5 2 2 2 3 3 1 3 3
Beneish M-Score — — — — — -2.22 — — -9.63 -1.58 -2.52 -1.82 -8.09 0.08 2.02 -4.53 -2.37 -7.58 — 28.29 28.289
Ohlson O-Score snapshot only -0.209
Net-Net WC snapshot only $-0.04
Credit
Metric Trend Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Credit Rating snapshot only B-
Credit Score 20.00 58.26 58.31 58.17 59.72 36.37 20.00 20.00 20.00 33.15 38.55 33.54 33.50 41.82 34.93 20.00 20.00 20.00 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 38
Sector Credit Rank snapshot only 33

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms